Table 2 Demographic data of group B (13–35 months, n = 106)
From: The efficacy and safety of mivacurium in pediatric patients
Subgroups | n | Percentage in group A (%) | Sex (M/F) | Body weight (kg) | Induction dose (mg/kg) | Injecting time (s) |
|---|---|---|---|---|---|---|
Group 5 | 29 | 27 | 21/8 | 13.1 ± 6.1 | 0.20 | 20 |
Group 6 | 25 | 24 | 17/8 | 11.5 ± 2.1 | 0.20 | 40 |
Group 7 | 28 | 26 | 19/9 | 14.3 ± 7.2 | 0.25 | 20 |
Group 8 | 24 | 23 | 12/12 | 12.6 ± 3.1 | 0.25 | 40 |